Further, studies of breast cancer patients in the first 18 months after completing treatment suggest that psychological risk factors such as perceived stress may moderate the relationship between inflammation (i.e., CRP in one study, and the combination of CRP, IL-6, and sTNF-RII in another study) and depression [39,40]. This evidence concerns the gene CRP and depressive symptom measurement.